The IPEC Federation is a global organization that promotes quality in pharmaceutical excipients. The IPEC Federation represents the four existing regional International Pharmaceutical Excipient Councils (IPECs) - IPEC Americas, IPEC Europe, IPEC Japan and IPEC China - and provides a unified voice to promote the best use of excipients in medicines as a means of improving patient treatment and safety.
Excipients play a critical role in the manufacture of medicines by helping to preserve the efficacy, safety, and stability of active pharmaceutical ingredients (APIs), and helping to ensure that they deliver their promised benefits to patients.
Optimal use of excipients provides pharmaceutical manufacturers with drug development cost-savings, enhanced functionality capability and can also assist in drug formulation innovation.
IPEC Federation Published Position Paper on Third Party Audit and Certification Programmes
The IPEC Federation believes that independent, third party auditing and certification of excipient suppliers can assist in the development, manufacture and supply of safe and effective medic more >
Five more certificates underscore EXCiPACT progress
EXCiPACT certificates continue to be issued by the registered and approved third-party certifying bo more >
Ideal Cures Pvt. Ltd. of India has recently been awarded two EXCiPACT™ Certificates
NEWS RELEASE: IDEAL CURES Pvt. Ltd. IS THE FIRST INDIAN COMPANY TO RECEIVE EXCiPACTTM CERTIFICATION more >
IPEC Federation Publishes Position Paper on EU Risk Assessment Guidelines for Excipients
Problem statement: The IPEC Federation (IPEC) acknowledges and welcomes the risk-based approach of more >
APV/IPEC Europe Excipient Conference 2015
IPEC Europe and APV are delighted to invite you once again to our annual conference on pharmaceutical excipients, which will take place in Barcelona, more >
Madrid, Spain - 13-15 October the number one Pharma sourcing event J more >
Excipient GMP Auditor Workshop in Arlington, VA
Only 5 spaces remain: October 20-22, 2015 Arlington, Virginia (IPEC-Am more >
3 Workshops Focused on Risk Assessment - Arlington, Virginia
Did you know that ELEVEN sections of the new NSF/IPEC/ANSI 363-2 more >